Caris Life Sciences is a leading patient-centric next-generation AI TechBio company and precision medicine pioneer. The company operates the Caris Assure and Caris Discovery platforms for molecular profiling of cancer patients, enabling oncologists to match patients to targeted therapies and clinical trials.
Company Info
Upcoming Milestones & Key Dates
Additional clinical evidence publications
Clinical Development Pipeline
Recent News
/PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today...
Leadership Team
Chairman & CEO
EVP & Chief Financial Officer
Chief Medical Officer
Careers & Job Openings